Through a Citizen Petition submitted to the Food and Drug Administration (FDA) in September 2023 by Celiac Journey, which was founded by the Bari family, Jax is pushing the agency to issue a ...
After getting FDA approval for hearing aid detection on AirPods Pro 2 last week, the US Food and Drug Administration gave Apple a green light (via TechCrunch) for sleep apnea detection Apple Watch ...
Three Apple Watches have received approval for detecting sleep apnea, just in time for today’s launch of the feature in watchOS 11. The Federal Drug Administration approval was able to be ...
Neuralink, the medical technology company founded by Elon Musk, received an important clearance from the Food and Drug Administration that may allow the brain implant system to help people with ...
The FDA expanded approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease. The decision will free up access to the medication for tens of ...
The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease.
They found that only 13% of posts complied with FDA health warning guidelines ... To confirm brand ownership, profile images were compared to logos from official websites; 76% linked directly ...
The Food and Drug Administration sends warning letters to entities under its jurisdiction as part of its enforcement activities. Some letters are not posted for public view until weeks or months ...
(RTTNews) - Philips (PHG) Tuesday announced FDA approval for its LumiGuide endovascular navigation wire. The LumiGuide guidewire, which utilizes the company's breakthrough Fiber Optic RealShape ...
Neuralink recently announced that it has received "Breakthrough Device Designation" from the FDA for Blindsight, a device designed to restore vision to those who can no longer see. According to ...
The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease, drugmaker Novartis said Tuesday.
(RTTNews) - Biopharmaceutical company BridgeBio Pharma, Inc. (BBIO) announced Tuesday that the US FDA has granted Breakthrough Therapy Designation to oral infigratinib under development for ...